vs
Array Technologies, Inc.（ARRY）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Array Technologies, Inc.的季度营收约是Orthofix Medical Inc.的1.0倍（$226.0M vs $219.9M），Orthofix Medical Inc.同比增速更快（2.0% vs -17.9%），Array Technologies, Inc.自由现金流更多（$36.2M vs $16.8M），过去两年Array Technologies, Inc.的营收复合增速更高（21.4% vs 8.0%）
ATI科技是原加拿大半导体科技企业，总部位于安大略省万锦市，专注于图形处理器与芯片组的研发，1985年成立，1993年公开上市，2006年被AMD收购。作为全球知名的无晶圆厂半导体厂商，其掌握自研核心技术，生产组装环节采用外包模式。2000年3dfx破产后，ATI成为全球图形芯片领域的核心厂商之一。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ARRY vs OFIX — 直观对比
营收规模更大
ARRY
是对方的1.0倍
$219.9M
营收增速更快
OFIX
高出19.8%
-17.9%
自由现金流更多
ARRY
多$19.3M
$16.8M
两年增速更快
ARRY
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $226.0M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | 8.6% | 71.1% |
| 营业利润率 | -65.5% | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | -17.9% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $-1.06 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARRYOFIX
| Q4 25 | $226.0M | $219.9M | ||
| Q3 25 | $393.5M | $205.6M | ||
| Q2 25 | $362.2M | $203.1M | ||
| Q1 25 | $302.4M | $193.6M | ||
| Q4 24 | $275.2M | $215.7M | ||
| Q3 24 | $231.4M | $196.6M | ||
| Q2 24 | $255.8M | $198.6M | ||
| Q1 24 | $153.4M | $188.6M |
净利润ARRYOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $33.5M | $-22.8M | ||
| Q2 25 | $43.3M | $-14.1M | ||
| Q1 25 | $16.7M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $-141.4M | $-27.4M | ||
| Q2 24 | $25.7M | $-33.4M | ||
| Q1 24 | $2.2M | $-36.0M |
毛利率ARRYOFIX
| Q4 25 | 8.6% | 71.1% | ||
| Q3 25 | 26.9% | 72.2% | ||
| Q2 25 | 26.8% | 68.7% | ||
| Q1 25 | 25.3% | 62.8% | ||
| Q4 24 | 28.5% | 69.0% | ||
| Q3 24 | 33.8% | 68.7% | ||
| Q2 24 | 33.6% | 67.8% | ||
| Q1 24 | 35.9% | 67.5% |
营业利润率ARRYOFIX
| Q4 25 | -65.5% | 0.2% | ||
| Q3 25 | 11.6% | -8.3% | ||
| Q2 25 | 12.8% | -7.9% | ||
| Q1 25 | 9.0% | -25.2% | ||
| Q4 24 | -51.7% | -5.3% | ||
| Q3 24 | -57.3% | -9.6% | ||
| Q2 24 | 15.5% | -12.5% | ||
| Q1 24 | 5.5% | -15.6% |
净利率ARRYOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 8.5% | -11.1% | ||
| Q2 25 | 11.9% | -6.9% | ||
| Q1 25 | 5.5% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | -61.1% | -13.9% | ||
| Q2 24 | 10.0% | -16.8% | ||
| Q1 24 | 1.4% | -19.1% |
每股收益（稀释后）ARRYOFIX
| Q4 25 | $-1.06 | $-0.05 | ||
| Q3 25 | $0.12 | $-0.57 | ||
| Q2 25 | $0.19 | $-0.36 | ||
| Q1 25 | $0.02 | $-1.35 | ||
| Q4 24 | $-0.94 | $-0.76 | ||
| Q3 24 | $-1.02 | $-0.71 | ||
| Q2 24 | $0.08 | $-0.88 | ||
| Q1 24 | $-0.07 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $244.4M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-206.3M | $450.0M |
| 总资产 | $1.5B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARRYOFIX
| Q4 25 | $244.4M | $82.0M | ||
| Q3 25 | $221.5M | $62.9M | ||
| Q2 25 | $377.3M | $65.6M | ||
| Q1 25 | $348.3M | $58.0M | ||
| Q4 24 | $363.0M | $83.2M | ||
| Q3 24 | $332.4M | $30.1M | ||
| Q2 24 | $282.3M | $26.4M | ||
| Q1 24 | $287.6M | $27.0M |
总债务ARRYOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ARRYOFIX
| Q4 25 | $-206.3M | $450.0M | ||
| Q3 25 | $-46.7M | $442.5M | ||
| Q2 25 | $-70.9M | $458.3M | ||
| Q1 25 | $-97.8M | $458.3M | ||
| Q4 24 | $-118.1M | $503.1M | ||
| Q3 24 | $64.5M | $525.9M | ||
| Q2 24 | $200.0M | $546.0M | ||
| Q1 24 | $231.2M | $570.3M |
总资产ARRYOFIX
| Q4 25 | $1.5B | $850.6M | ||
| Q3 25 | $1.6B | $832.6M | ||
| Q2 25 | $1.5B | $837.2M | ||
| Q1 25 | $1.4B | $823.1M | ||
| Q4 24 | $1.4B | $893.3M | ||
| Q3 24 | $1.6B | $867.9M | ||
| Q2 24 | $1.7B | $882.0M | ||
| Q1 24 | $1.6B | $906.0M |
负债/权益比ARRYOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $43.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $36.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 16.0% | 7.6% |
| 资本支出强度资本支出/营收 | 3.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $79.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ARRYOFIX
| Q4 25 | $43.6M | $27.7M | ||
| Q3 25 | $27.4M | $12.4M | ||
| Q2 25 | $43.8M | $11.6M | ||
| Q1 25 | $-13.1M | $-18.4M | ||
| Q4 24 | $57.6M | $23.7M | ||
| Q3 24 | $44.9M | $11.7M | ||
| Q2 24 | $4.0M | $9.0M | ||
| Q1 24 | $47.5M | $-18.6M |
自由现金流ARRYOFIX
| Q4 25 | $36.2M | $16.8M | ||
| Q3 25 | $21.9M | $2.5M | ||
| Q2 25 | $37.2M | $4.5M | ||
| Q1 25 | $-15.4M | $-25.1M | ||
| Q4 24 | $55.9M | $15.2M | ||
| Q3 24 | $43.9M | $6.3M | ||
| Q2 24 | $1.8M | $-360.0K | ||
| Q1 24 | $45.1M | $-29.1M |
自由现金流率ARRYOFIX
| Q4 25 | 16.0% | 7.6% | ||
| Q3 25 | 5.6% | 1.2% | ||
| Q2 25 | 10.3% | 2.2% | ||
| Q1 25 | -5.1% | -13.0% | ||
| Q4 24 | 20.3% | 7.0% | ||
| Q3 24 | 19.0% | 3.2% | ||
| Q2 24 | 0.7% | -0.2% | ||
| Q1 24 | 29.4% | -15.4% |
资本支出强度ARRYOFIX
| Q4 25 | 3.3% | 4.9% | ||
| Q3 25 | 1.4% | 4.8% | ||
| Q2 25 | 1.8% | 3.5% | ||
| Q1 25 | 0.8% | 3.5% | ||
| Q4 24 | 0.6% | 4.0% | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 0.8% | 4.7% | ||
| Q1 24 | 1.6% | 5.6% |
现金转化率ARRYOFIX
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | -0.78× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 21.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARRY
| Array Legacy Operations Segment | $212.0M | 94% |
| STI Operations Segment | $14.0M | 6% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
